A tool to evaluate potential transplant candidates that looks at tumor marker levels in the blood can help predict which liver cancer patients are most likely to have their disease remain under control after receiving a transplant, according to a new study led by investigators at Weill Cornell Medicine and NewYork-Presbyterian.
